In Regard to Chang et al

Affiliations

¹ Department of Radiation Oncology and Image-Applied Therapy, Kyoto University Hospital, Kyoto, Japan.
² Radiation Oncology Center, Ofuna Chuo Hospital, Kanagawa, Japan.
³ Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama City, Japan.

Comment

Yudai Tateishi et al. Int J Radiat Oncol Biol Phys. 2022.

. 2022 Feb 1;112(2):574.

doi: 10.1016/j.ijrobp.2021.09.050.

¹ Department of Radiation Oncology and Image-Applied Therapy, Kyoto University Hospital, Kyoto, Japan.
² Radiation Oncology Center, Ofuna Chuo Hospital, Kanagawa, Japan.
³ Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama City, Japan.

No abstract available

Comment on

Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery.
Chang JY, Mehran RJ, Feng L, Verma V, Liao Z, Welsh JW, Lin SH, O'Reilly MS, Jeter MD, Balter PA, McRae SE, Berry D, Heymach JV, Roth JA; STARS Lung Cancer Trials Group. Chang JY, et al. Lancet Oncol. 2021 Oct;22(10):1448-1457. doi: 10.1016/S1470-2045(21)00401-0. Epub 2021 Sep 13. Lancet Oncol. 2021. PMID: 34529930 Free PMC article. Clinical Trial.